Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Oncology CRO Solutions

Offering Global Oncology CRO Services Focused on Early Phase Oncology Research.

Oncology and hematology are highly nuanced areas of research because every indication requires unique solutions. Our oncology CRO services team has the deep expertise to expedite early phase oncology trials and support emerging biotech. 

We go the distance - to help you create a healthier world. 

Request A Proposal

Oncology Expertise You Can Depend On

When you choose a team with the right kind of clinical trial oncology experience, you set your study up for success. For more than 20 years, we have specialized in oncology clinical trials supporting global clinical research across a wide variety of indications including:

Oncology-Experience-Wheel@2x

 

Brain
Breast
Colorectal
Hepatocellular
Leukemia
Lung
Lymphoma
Pancreatic
Prostate

Oncology CRO Expertise – Working for You

Expedited Early Phase

Accelerating early phase research is critical to sponsors and patients. With over 50% of PM’s and over 60% of CRA’s at Pharm-Olam experienced in early phase oncology trials including complex adaptive designs and FIH trials, and with a specialization in early phase hematology-oncology research, including leukemia, lymphoma, and myeloma, we are ideally positioned to expedite your next Phase I-II trial.

Our oncology CRO team has invested in advantageous site and vendor relationships with process optimizations and checkpointed cohort management techniques to expedite your early-phase study.

Oncology Aligned Staff

At Pharm-Olam, we maintain therapeutically-aligned staff with deep expertise in Oncology. From solid tumor to liquid tumor, our oncology CRO staff have the expertise you need to go the distance.

Staff with Oncology study expertise.

  • 88% of our Project Managers
  • 83% of our CRAs

Built for Small & Emerging

Pharm-Olam has championed small pharma and biotech companies since the earliest developments in the field. Over 85% of our experience is with  small and emerging pharma and biotech. We continue those efforts today. With Pharm-Olam, you will find an agile Clinical Research Organization (CRO) focused on finding trial-specific solutions to accelerate your study execution. We go the distance – helping you create a healthier world. 

Hematology CRO Services

Our Hematology experience includes liquid tumor expertise as well as numerous non-cancerous hematology diseases.  From rare hematology disorders to common diseases, we have gone the distance for our patients and are ready to support your hematology drug development.

Hematology CRO Services >>

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Our teams have executed studies for hematology treatments across a wide variety of indications.

-

An Immuno-Oncology Case Study

Phase I Solid Tumor PD-1 Inhibitor Study Enrolled 78 Days Early

Pharm-Olam was hired by a sponsor to run a PD-1 Inhibitor Phase I oncology study in solid tumor patients.  The study moved swiftly and we completed enrollment 78 days early.  

Read The Case Study

PD-1-Case-study-graphic-sm

 

An Immuno-Oncology Case Study

Phase I Solid Tumor PD-1 Inhibitor Study Enrolled 78 Days Early

Pharm-Olam was hired by a sponsor to run a PD-1 Inhibitor Phase I oncology study in solid tumor patients.  The study moved swiftly and we completed enrollment 78 days early.  

Read The Case Study

Need a partner for your next oncology-hematology study?

Our team is dedicated and ready to assist.  Talk with our team today.